在中国,临床药剂师构建并实证研究了中国临床药剂师对外科期间药物管理能力模型
Zijing Zhao1, Mengdi Sheng2, Yue Qiu3
1Department of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China; Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Research in social & administrative pharmacy : RSAP
|March 5, 2026
概括
这项研究为临床药剂师开发了术后药物管理方面的能力模型,显著改善了患者的治疗结果并降低了成本. 该模型提高了药剂师资格和治疗管理,从而改善了医疗保健.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 医疗保健管理的管理
背景情况:
- 与药物相关的问题 (DRP) 是术后护理的一个重要问题.
- 错误的药物决定增加了患者的风险,成本和资源浪费.
研究的目的:
- 提高临床药剂师的术后药物管理技能.
- 开发和验证中国临床药剂师的能力模型.
- 为了改善患者的坚持和临床结果.
主要方法:
- 文献审查和专家咨询.
- 国家调查开发和Delphi方法用于模型构建.
- 确认因素分析和在第三级医院进行了为期六个月的经验研究.
主要成果:
- 完成了一个四维能力模型:资格,治疗管理,团队合作和学术参与.
- 术期药物治疗管理是最有影响力的因素.
- 模型指导训练减少了感染率 (55.6%),抗微生物药物持续时间 (0.61天),呼吸系统症状 (51.4%),疼痛评分,改善了愈合时间.
- 显著的经济效益包括减少总治疗成本 (25.8%) 和质子抑制剂支出 (97.5%).
结论:
- 为中国临床药剂师在术后药物管理方面开发了一种能力指标系统.
- 该系统提高了临床药剂师在这个关键领域的实践的整体标准.
相关概念视频
Three-Compartment Open Model
1.1K
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
1.1K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
56
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
56
Clearance Models: Compartment Models
1.5K
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
1.5K
Pharmacokinetic Models: Overview
2.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.4K
Model Approaches for Pharmacokinetic Data: Compartment Models
669
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
669
One-Compartment Open Model for IV Bolus Administration: General Considerations
869
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
869
